A focus on the synapse for neuroprotection in Alzheimer disease and other dementias.
about
Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbilsTNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot studyThe "quad-partite" synapse: microglia-synapse interactions in the developing and mature CNSMolecular mechanism of acrylamide neurotoxicity: lessons learned from organic chemistryProteolytic cleavage of apolipoprotein E4 as the keystone for the heightened risk associated with Alzheimer's diseaseAlzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss.PAK in Alzheimer disease, Huntington disease and X-linked mental retardationImpaired balance of mitochondrial fission and fusion in Alzheimer's diseaseAlzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.Seizure susceptibility and mortality in mice that over-express amyloid precursor proteinCarvedilol as a potential novel agent for the treatment of Alzheimer's disease.Can multi-modal neuroimaging evidence from hippocampus provide biomarkers for the progression of amnestic mild cognitive impairment?Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease.Advances in functional magnetic resonance imaging: technology and clinical applications.Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies.Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine.Long-term neurocognitive dysfunction in offspring via NGF/ ERK/CREB signaling pathway caused by ketamine exposure during the second trimester of pregnancy in rats.A novel effect of rivastigmine on pre-synaptic proteins and neuronal viability in a neurodegeneration model of fetal rat primary cortical cultures and its implication in Alzheimer's diseaseAbnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.Caffeine consumption prevents diabetes-induced memory impairment and synaptotoxicity in the hippocampus of NONcZNO10/LTJ mice.7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer's disease.Fractionating verbal episodic memory in Alzheimer's diseaseCombining comparative proteomics and molecular genetics uncovers regulators of synaptic and axonal stability and degeneration in vivoFunctional alterations in memory networks in early Alzheimer's disease.Early Hippocampal Synaptic Loss Precedes Neuronal Loss and Associates with Early Behavioural Deficits in Three Distinct Strains of Prion Disease.Effects of electromagnetic radiation on spatial memory and synapses in rat hippocampal CA1.Activation of caspase-6 in aging and mild cognitive impairmentDiet-induced changes in brain structure and behavior in old gerbilsNeurological diseases as primary gliopathies: a reassessment of neurocentrismPositive lysosomal modulation as a unique strategy to treat age-related protein accumulation diseasesBlockade of adenosine A2A receptors prevents interleukin-1β-induced exacerbation of neuronal toxicity through a p38 mitogen-activated protein kinase pathway.Region specific neuron loss in the aged canine hippocampus is reduced by enrichment.Mitoenergetic failure in Alzheimer disease.Delayed amyloid plaque deposition and behavioral deficits in outcrossed AβPP/PS1 mice.Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 Tat transgenic mice.The triggering receptor expressed on myeloid cells 2: "TREM-ming" the inflammatory component associated with Alzheimer's diseaseDynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients.Microglia and synapse interactions: fine tuning neural circuits and candidate moleculesMolecular mechanisms of the conjugated alpha,beta-unsaturated carbonyl derivatives: relevance to neurotoxicity and neurodegenerative diseases.The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals.
P2860
Q24670540-B5ECC470-D82B-44EE-923C-5C3916B98C09Q24681139-E7DEC12F-FD4C-458A-BAB2-52CF431F0D38Q26825543-5908003B-5672-42F3-889B-CC5552CFDC5DQ26999354-BA0B16D5-F9A8-481A-A580-F0DD2E86799EQ27011311-6ED16844-609C-434F-AC99-9A1C2A9FC666Q27303472-04DE43BD-109B-4E23-96A2-C8224840339CQ28279479-58D18AEF-DB29-4A24-B560-3EFE05330CF4Q28854335-7F7C411B-945B-4E39-BDB8-679904666916Q30478477-85BA501E-CA94-4ACB-8363-08F62F47EAF0Q30482779-4DC7A311-1048-4543-93A3-1E83311D11A3Q30497187-E8411CAE-820C-4314-8884-3E770B333B43Q30884744-4EC5E40D-3696-4D31-9AAC-22DF663B49AEQ30989943-080E7ED7-B6FA-437C-9B4B-3DE16CC726E2Q31117150-FE4E25E6-85EA-41AA-923A-615D5E1369E2Q31143202-39F09C12-3A4A-4EFF-88A4-5017B7BF2CC0Q33344779-54F68145-ACE6-4851-A923-9E7244F843DDQ33761594-4C0F0627-046A-4118-9A48-BA3BD94C3192Q33896054-7E92047E-7B39-456F-8600-73FD0D19D2B8Q33897771-97EA952E-5ABF-4638-9344-4D31706BA8A5Q34238362-19758298-E197-4522-80CB-BB06D9838892Q34370099-569ADFBE-8300-493E-A3B2-69DB1218E357Q34380479-0A6CD093-78BF-465E-A157-260D62FD1F21Q34404567-3C57721E-917A-43D3-AEE3-2D08D0203F19Q34565270-FA46DDA9-D113-4F8A-9B11-5993BD5C8385Q34808386-895D0E0C-E027-4FA7-874A-139974CB6D2FQ35109283-062B84F9-F46A-48E6-8C30-3881A11254F3Q35691585-0C662BE9-1CC5-4CFA-AACE-52460F7E4FB8Q35819175-E13FF8B3-53E5-4370-80E3-1E1230D80C72Q35872654-B8E6EF26-6D2F-48F8-9CFE-EA3E979D677CQ35904520-FFF5CBD1-F542-4634-8AB6-7D9CF4B86361Q36226674-3CCD4FE3-5C4B-45A6-947B-DD1D743B5B4AQ36380222-6D2A80A1-1D91-483D-9480-2851110C9280Q36522646-14C697CD-C663-4CC4-8A30-DF443C8F52FFQ36582377-F341347F-A978-4ABB-9421-053CECC47919Q36605014-7B6462B0-3CB6-4265-B4F8-D9EEABB8D904Q36711780-85096FAE-2ED2-43E8-B9A8-9DAFB5939424Q36778260-FBB75552-4088-4432-A63E-1DEBB9AC29DCQ36844607-366BAEB9-8851-403F-93C9-C4595015CF3FQ37033629-D8D94E86-222C-47C3-BBBB-D7D262AD1EDAQ37090083-E2F16F2D-887D-4B8B-9315-AA60AE0916D8
P2860
A focus on the synapse for neuroprotection in Alzheimer disease and other dementias.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
A focus on the synapse for neuroprotection in Alzheimer disease and other dementias.
@ast
A focus on the synapse for neuroprotection in Alzheimer disease and other dementias.
@en
type
label
A focus on the synapse for neuroprotection in Alzheimer disease and other dementias.
@ast
A focus on the synapse for neuroprotection in Alzheimer disease and other dementias.
@en
prefLabel
A focus on the synapse for neuroprotection in Alzheimer disease and other dementias.
@ast
A focus on the synapse for neuroprotection in Alzheimer disease and other dementias.
@en
P2093
P1433
P1476
A focus on the synapse for neuroprotection in Alzheimer disease and other dementias.
@en
P2093
Howard Federoff
Paul Coleman
Roger Kurlan
P304
P356
10.1212/01.WNL.0000140626.48118.0A
P407
P577
2004-10-01T00:00:00Z